Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
AdBio Partners is a venture capital firm based in Paris, France, specializing in early-stage investments in life sciences. The firm was established to act as a catalyst for creating companies based on innovations from academic research. Formerly known as Advent France Biotechnology, AdBio Partners has evolved to focus on supporting startups that address significant medical needs through innovative therapeutics.
Founded in 2017, AdBio Partners manages a fund size of $74 million and has built a portfolio of 18 companies. The firm collaborates with leading research institutions and technology transfer offices throughout Europe, leveraging a strong network to identify and support promising startups in the life sciences sector. Their commitment to early-stage investments allows them to play a crucial role in the development of groundbreaking therapies.
AdBio Partners operates from its Paris office and has a presence in Barcelona, Spain. The firm has established itself as a key player in the European biotech landscape, focusing on therapeutic areas such as oncology, immunology, ophthalmology, and rare diseases. Their approach combines financial investment with hands-on support, ensuring that portfolio companies receive the guidance necessary to thrive in a competitive market.
AdBio Partners invests in early-stage life sciences startups, specifically targeting therapeutic areas including oncology, immunology, ophthalmology, and rare diseases. The firm seeks to support innovative projects that have the potential to deliver first- or best-in-class products, addressing high unmet medical needs. Their investment strategy emphasizes collaboration with academic research institutions and technology transfer offices across Europe, allowing them to source disruptive healthcare innovations.
The firm typically engages in pre-seed, seed, seed-plus, and Series A funding rounds, providing check sizes that align with the needs of early-stage companies. AdBio Partners looks for founders who demonstrate a strong vision and commitment to their projects, as well as a willingness to collaborate closely with the firm. Their deal structure often includes hands-on support, ensuring that startups not only receive capital but also the entrepreneurial guidance necessary for growth.
AdBio Partners manages a diverse portfolio of 18 companies, each focused on innovative therapeutic solutions in the life sciences sector. Notable portfolio companies include:
This portfolio reflects AdBio Partners' commitment to supporting companies that are at the forefront of addressing critical healthcare challenges through innovative therapies.
Alain HURIEZ: Chairman and Managing Partner. Alain has extensive experience in the life sciences sector and has been instrumental in guiding the firm's investment strategy.
Clément BERTHOLET: Managing Partner. Clément brings a wealth of knowledge in venture capital and has a strong background in supporting early-stage biotech companies.
Emma GASOL: Partner. Emma has a proven track record in identifying promising startups and providing strategic guidance to portfolio companies.
Céline DE COSNAC: Chief Financial Officer. Céline oversees the financial operations of the firm, ensuring sound financial management and reporting.
Adrien CLAVAIROLY: Principal. Adrien plays a key role in sourcing and evaluating investment opportunities within the life sciences sector.
Sofia ARNAL: Associate. Sofia supports the investment team in due diligence and portfolio management activities.
Anna CRESPO PUIG: Analyst. Anna conducts market research and analysis to inform investment decisions.
Geoffroy DE RIBAINS: Venture Partner. Geoffroy brings valuable insights from his extensive experience in the biotech industry.
Laurence DE SCHOULEPNIKOFF: Venture Partner. Laurence has a strong background in venture capital and supports the firm's investment strategy.
Mounia AZZI: Venture Partner. Mounia focuses on identifying innovative startups and supporting their growth.
Jacques DUMAS: Venture Partner. Jacques has a wealth of experience in the life sciences sector and contributes to the firm's investment decisions.
TsungYen WU: Entrepreneur In Residence. TsungYen provides mentorship and guidance to portfolio companies.
Sandie LARTILLEUX: Middle Officer. Sandie supports the operational aspects of the firm and assists in managing portfolio companies.
To pitch AdBio Partners, founders should visit their website at adbio.partners. It is advisable to include a comprehensive pitch deck that outlines the startup's vision, market opportunity, and team qualifications. While specific response time expectations are not disclosed, founders can expect a thorough review process.
Warm introductions are preferred, especially from mutual connections within the life sciences sector. This can enhance the likelihood of receiving feedback and engagement from the firm.
In recent months, AdBio Partners has been actively involved in the life sciences sector, highlighting significant developments within their portfolio companies. Notable events include leadership appointments and positive clinical trial results, showcasing the ongoing momentum of their investments.
In June 2024, AdBio Partners co-launched AndzonBio, a dual entity focused on cardiovascular, renal, and metabolic disorders, in collaboration with Inserm Transfert. This initiative reflects the firm's commitment to fostering innovation in the biotech space.
Additionally, AdBio Partners participated in the oversubscribed Series A funding round for Augustine Therapeutics, which raised approximately €77.7 million ($85 million) to support its HDAC6 inhibitor portfolio targeting neuromuscular and neurodegenerative diseases.
What are AdBio Partners' investment criteria?
AdBio Partners focuses on early-stage life sciences startups, particularly in therapeutic areas such as oncology, immunology, ophthalmology, and rare diseases. They look for projects that address significant medical needs and have the potential to deliver first- or best-in-class products.
How can I pitch to AdBio Partners?
Founders can pitch to AdBio Partners through their website at adbio.partners. It is recommended to include a detailed overview of the project, the team, and the market opportunity in the pitch deck.
What makes AdBio Partners different from other investors?
AdBio Partners differentiates itself through its strong network in the life sciences sector and its hands-on approach to supporting portfolio companies. They collaborate closely with startups, providing entrepreneurial guidance and facilitating connections with leading research institutions.
What is the geographic focus of AdBio Partners?
The firm primarily invests in Europe, with a strong emphasis on France. They collaborate with various research institutions and technology transfer offices across the continent.
What is the typical check size for investments?
While specific check sizes are not publicly disclosed, AdBio Partners typically engages in pre-seed, seed, seed-plus, and Series A funding rounds, aligning their investments with the needs of early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.